Sen. Elizabeth Warren (D-Mass.) penned a letter with 19 other senators to the maker of EpiPens Tuesday, questioning the company’s recent attempt to address the outrage over its price hikes.
The senators — 19 Democrats and Independent Sen. Bernie Sanders (Vt.), who caucuses with Democrats — grilled Mylan about why it did not reduce the price of the EpiPen, an emergency allergy medication, and instead put forward more complicated discounting systems in response to the uproar about skyrocketing prices.
Mylan, for example, expanded its program to provide discount cards to consumers. But the senators said that while consumers may be insulated from the price with such discounts, the insurer still has to pay a hefty cost, which in turn raises premiums.